## CB: Chubb Limited - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 2.6% below STRENGTH zone (4.0-10.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($304.31)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Chubb Limited Appoints John Depeters as Executive Vice President, Head of Commercial Insurance and Specialty**
- Source: marketscreener.com | 20251223T203845 | Somewhat-Bullish | Relevance: 100%
- Chubb Limited has appointed John DePeters as Executive Vice President, Head of Commercial Insurance and Specialty for Chubb Overseas General Insurance (COG). Mr. DePeters, who has over 13 years of insurance experience, will be based in London. This new role will see him leading the commercial and specialty insurance operations for COG.

**2. People Moves: Chubb Overseas General Promotes DePeters to Lead Commercial Insurance, Specialty; BMS Taps Emkes From Lockton as Director of Commercial D&O**
- Source: Insurance Journal | 20251222T160728 | Bullish | Relevance: 100%
- Chubb Overseas General Insurance has appointed John DePeters as executive vice president, head of Commercial Insurance and Specialty, effective January 1, 2026. In another move, BMS, the independent insurance and reinsurance broker, announced the appointment of Charlie Emkes as director of commercial directors and officers (D&O) solutions, effective from January 2026. Emkes joins from Lockton with over 12 years of experience in the London Market.

**3. Shikiar Asset Management Inc. Has $3.29 Million Position in Chubb Limited $CB**
- Source: MarketBeat | 20251223T130747 | Somewhat-Bullish | Relevance: 100%
- Shikiar Asset Management Inc. significantly reduced its stake in Chubb Limited by 48.0% in Q3, now holding 11,640 shares valued at approximately $3.29 million. Despite this, Chubb reported strong quarterly earnings, surpassing analyst expectations, and announced a quarterly dividend, while institutional investors collectively own 83.81% of the stock. Analysts currently maintain a consensus "Hold" rating for Chubb with a target price of $311.90.

**4. Healthy Paws Pet Foundation at Chubb Donates $275,000 to Animal Rescue Organizations Across the United States to Support Adoption and Ongoing Care for Vulnerable Pets**
- Source: Finviz | 20251222T100000 | Somewhat-Bullish | Relevance: 100%
- The Healthy Paws Pet Foundation at Chubb has donated a total of $275,000 to seven animal rescue organizations across the United States. These funds are intended to support pet adoption and ongoing care for vulnerable animals, helping the recipient organizations expand their lifesaving initiatives and find forever homes for pets. This initiative underscores Healthy Paws' commitment to facilitating pet rescue and care, from adoption through veterinary visits and ongoing medical needs.

**5. Healthy Paws Pet Foundation at Chubb Donates $275,000 to Animal Rescue Organizations**
- Source: Pet Age | 20251222T220728 | Bullish | Relevance: 100%
- The Healthy Paws Pet Foundation at Chubb has donated $275,000 to seven animal rescue organizations across the country. This initiative is part of Healthy Paws' ongoing commitment to supporting pet rescue and care, enabling these organizations to expand their life-saving work for animals with behavioral and medical needs. The contributions aim to facilitate adoptions and ensure pets receive necessary care.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Mizuho | $318 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Mizuho | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($14.78M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.3%)
- Berkshire Hathaway, : 7.6% (+15.9%)
- Blackrock Inc.: 6.7% (+0.6%)
- State Street Corpora: 4.1% (+0.4%)
- FMR, LLC: 3.0% (-11.2%)

### Key Risks

1. Heavy insider selling: $15M sold (7 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Quality metrics strong (margin 16%). Balance sheet: strong liquidity (10.9x). Insider selling cluster ($14.8M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $124.9B |
| Beta | 0.52 |
| 52W Range | $252.16 - $314.12 |
| Short Interest | 0.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 11.9 |
| Current P/E | 13.2 |
| YoY Growth | 11.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 6.7% to 2.6% (-4.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 (-1.1%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.6% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.58), confirming momentum. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.56% (CS: 78) | Neutral |
| RSI_14 | 69.9 | Neutral |
| MACD Histogram | 0.58 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.074x | Above |
| vs SMA200 | 1.099x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $313.19
- **Stop Loss:** $304.31 (2.8% risk)
- **Target:** $322.07 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 101
- **Position Value:** $31,632.19
- **Portfolio %:** 31.63%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-27 (Est: $6.49)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.16 | $7.49 | +21.7% |
| 2025Q2 | $5.97 | $6.14 | +2.8% |
| 2025Q1 | $3.23 | $3.68 | +14.0% |
| 2024Q4 | $5.45 | $6.02 | +10.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*